Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Indian Pediatr ; 60(10): 834-838, 2023 10 15.
Article in English | MEDLINE | ID: mdl-37480296

ABSTRACT

OBJECTIVE: To determine the prevalence of impaired growth parameters (height and BMI z scores) among adolescents aged 10-19 years, with onset of idiopathic nephrotic syndrome between the age of 1 and 6 years. METHODS: A cross-sectional study was conducted among adolescents aged 10-19 years with onset of idiopathic nephrotic syndrome between the age of 1-6 years, and under regular follow-up at our center. The data were retrieved for a 10-year period (2012-2022). The current weight, height and body mass index (BMI) were recorded and interpreted as per world Health Organization (WHO) growth standards. RESULTS: 116 adolescents [60 Frequently relapsing nephrotic syndrome (FRNS)/Steroid dependent nephrotic syndrome (SDNS), and 56 Steroid resistant nephrotic syndrome (SRNS)] patients were enrolled with median (IQR) age of 133 (120,168) months and age at disease onset of 48 (26,68) months. The proportion of children with overweight (BMI for age >1z and cushingoid features), obesity (BMI for age >2z), stunting (height for age (HFA) <2z), and severe stunting (HFA <3z) were 29 (25%), 3 (2.6%), 31 (26.7%), and 7 (6%), respectively. The median (IQR) cumulative steroid dose for FRNS/SDNS and SRNS group was 19986.96 (14597.1, 26181.96) mg/m2 and 14385 (10758.82, 21355.95) mg/m2, respectively (P=0.003). CONCLUSION: The proportion of short stature and overweight was high among adolescents with nephrotic syndrome, emphasizing the need for measures to reduce steroid use and other measures to support growth.


Subject(s)
Glucocorticoids , Growth Disorders , Nephrotic Syndrome , Overweight , Adolescent , Child , Child, Preschool , Humans , Infant , Cross-Sectional Studies , Growth Disorders/chemically induced , Growth Disorders/diagnosis , Growth Disorders/etiology , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Nephrotic Syndrome/complications , Nephrotic Syndrome/drug therapy , Overweight/chemically induced , Overweight/diagnosis , Overweight/etiology , Recurrence , Young Adult , Prevalence , Glucocorticoids/adverse effects , Glucocorticoids/therapeutic use , Body Weights and Measures
SELECTION OF CITATIONS
SEARCH DETAIL
...